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 INTRODUCTION 
 
 
Leptospirosis is a worldwide public health problem. In humid 
tropical and subtropical areas, where most developing countries are 
found, it is a greater problem than in those with a temperate climate. It is 
difficult to confirm the diagnosis, because of lack of availability of 
cultures which is considered as the gold standard.3 Wide variety of 
serological tests are available with varying sensitivity and specificity. 
ELISA IgM , IgM-specific dot-ELISA, LEPTO Dipstick, slide 
agglutination method, Dri-Dot assay, complement fixation  assay, latex 
agglutination, indirect hemagglutination test, and indirect 
immunofluorescent test are to name a few.1, 2, 4-12Among these tests 
ELISA IgM has been considered the ideal one.13   
Clinical manifestations are non-specific in the early stages of 
illness. The early institution of antibiotic therapy has been found to be 
beneficial in studies. 1, 2, 14   Faines criteria has been recommended by the 
world health organization as a useful clinical tool in the diagnosis of 
Leptospirosis.15 However, there is paucity of data in literature regarding 
the usefulness of Faine’s criteria in pediatrics. Hence, a study to assess 
the usefulness of Faines and modified Faines criteria has been attempted. 
 
 HISTORY  
 
Adolf Weil first described Leptospirosis in 1886.16 In 1888  
Fieldler, named leptospirosis as “Weil's disease”. Huebner and Reiter and  
in 1915 demonstrated the organism in Germany and by Inado and Ido in 
Japan in the same year.17 In 1918 Noguchi coined the name ‘Leptospira’ 
(thin spirals), followed by  detailed microscopical examination and 
cultural studies. 18 
In 1917 the first isolate ‘icterohaemorrhagiae’ was named in 
Japan.  Later in 1918 isolated serovar was ‘hebdomadis’ (non icteric) and 
in 1925 serovar ‘autumnalis’ from autumnal fever patient. 
In the year 1925 in Indonesia serovar “bataviae” was isolated   
from an anicteric patient. Serovar “grippotyphosa” was the first animal 
isolate from cattle in USSR in 1928.  In 1933 “canicola” from 
Netherlands, in 1937 “Pomona” and “australis”  from Ballice , in 1944 
“ballum” and “saxkoebing” and from Denmark and  different  other 
serogroups were subsequently isolated in various places of the world 
from different animal and reservoir hosts. Faine and Yanagawa and Faine 
showed that Leptospires were analogous to other bacteria in structure and 
that characteristic antigens were associated with structural elements in the 
year 1966. 19 
Morphology 
The genus comprises of thin spiral organisms with 5-20 coils and 
hooked ends. This differentiates it from other spirochetes. A helically 
shaped cell cylinder and two periplasmic flagellae enable the organism to 
burrow into tissues. They arise from two sub terminally placed basal 
bodies. The helical configuration is right handed with more than 18 coils 
per cell. The organism stain poorly with aniline dyes and is best seen with 
fluorescent antibody and silver impregnation techniques (Fontana’s stain 
and Levadity’s stain) which stains them into a dark brown color against a 
yellow background.20 
Leptospirosis is an infectious disease caused by leptospira 
interrogans complex, which has over 20 sero groups and more than 200 
serovars. Rodents, domestic and wild animals form the reservoir of 
infection. Domestic animals such as cattle, dogs and pigs may act as 
carriers for several months (temporary carrier); rodents usually remain 
carriers throughout their life (permanent carrier). Thus rodents are 
considered the major reservoir of infection.15 
Leptospires are excreted in the urine of infected animals and 
human beings are affected when they come in contact with the infected 
urine directly or indirectly, when exposed to infected soil and surface 
water following monsoon rains. Therefore, the illness commonly occurs 
during the monsoon. The infection is probably transmitted when human 
beings walk through stagnant rainwater contaminated by urine of infected 
animals. Leptospires survive in dry soil for 6 hours where as in flooded 
conditions for 6 months. The organisms enter host through abraded skin 
of the feet during contact with infected water or through intact mucous 
membranes of eye, throat, and gut.  
Leptospirosis can occur in both urban and rural areas. In urban 
areas due to overcrowding, improper sanitation and drainage facilities 
spread infection to both human beings and animals. Along with this 
presence of cattle, domestic rats, pigs, stray dogs, bandicoots, poorly 
maintained slaughter houses and habit of bare foot walking contribute to 
the spread of infection21, 22. Persons of all ages and races are 
susceptible.3,23     The number of cases in a region often fluctuates from 
year to year due to various factors such as rainfall, flooding and animal 
infections.  Boiling water, using Iodine tablets and UV sterilisers are very 
effective methods against killing leptospira.29 One of the Methods stated 
by WHO for prevention of the disease is to interrupt the transmission 
route by providing clean drinking water. 30 In a study by Reis et al it was 
found that in people living in slum areas with less than 20 meters from an 
open sewage or garbage pit, the risk of contamination with Leptospira 
was 1.4 times higher than others and poverty was found to be an 
independent risk factor for infection. For every household daily per capita 
income increase of one US dollar, there was a respective 11% reduction 
in the infection risk. 31 
World scenario 
The number of human cases worldwide is not clearly known. With  
currently available reports, incidence ranges from approximately 0.1–1 / 
100 000 / year in temperate climates and  10–100 / 100000 in the humid 
tropics. During epidemics and in risk groups,  incidence may reach over 
100 / 100000.32 
Indian scenario 
Unreliability of data is still a major problem in evaluating the 
presence and the actual incidence of Leptospirosis in many Asian 
countries including India.33 A low index of suspicion of this disease 
coupled with the diversity and non-specificity of its presentation accounts 
for the significant number of cases that go un-recognized.2 Published data 
available for Andaman Islands; one of the endemic areas of the world has 
a documented incidence rate of 50/100,000. 33A sero-survey on humans 
by the Indian Council of Medical Research, Leptospirosis Task Force, 
indicated “high prevalence of leptospirosis” and endemicity in India.34 
Although national incidence data is not available for India, Leptospirosis 
has been recognized as a major health problem. Natural disasters and 
poor sanitary conditions have contributed to the multiple epidemics and 
several outbreaks of the disease in the recent years.35-39 
Mortality 
The mortality rate in severe leptospirosis  is in the range of 5-40%.. 
The mild form (90%) of the illness is rarely fatal. Immuno compromised 
and elderly people are at the highest risk. 40 
Pathogenesis 
The pathogenesis of Leptospirosis is based of the following mechanism 
1. Direct bacterial invasion 
2. Non–specific inflammatory factors 
3. Immunological reactions 
Once they have gained entry, leptospires spread through the blood 
stream to all organs. Multiplication occurs in both blood and tissues. 
Within 24 hours, the organism can be isolated in most tissues except 
brain, skeletal muscles and aqueous humour. After 48 hours, they can be 
isolated from all tissues.  Multisystem involvement results from bacterial 
invasion and toxic reaction. Clearance of the organisms is accomplished 
by phagocytosis and humoral mechanisms.  Leptospires rapidly disappear 
from the blood after the appearance of agglutinins. After the 
spirochetemic phase, which lasts from 4-7 days, the organisms can be 
recovered only from renal and ocular tissues.  Leptospiruria continues for 
1 to 4 weeks. 1, 2, 4 
Clinical manifestations 
 
Leptospirosis can manifest in as many presentations as follows.15, 21 
1. Anicteric Leptospirosis ( ~ >90%) 
 
2. Icteric Leptospirosis (Weil’s disease ~ < 10 %) 
 
3. Hemorrhagic fever with renal syndrome 
 
4. Atypical pneumonia syndrome 
 
5. Myocarditis 
 
6. Aseptic meningoencephalitis 
 
7. Ocular manifestations 
 
8. Unusual Clinical manifestations 
 
 
 
 
 
  
 
 
The incubation period is 7 – 14 days, but ranges from 2 – 21 days.  
In general, both anicteric and icteric cases follow a biphasic course, 
‘septicemia’ or ‘leptospiremic’ phase. 
 
 
 
 
  
 
Possible determinants of leptospirosis severity 41 
Virulence properties of infecting Leptospira 
Infectious inoculum at the time of exposure 
Preexisting immunity due to previous exposure 
Hormonal influences (men more commonly develop severe disease) 
Human host genetics: acquired or innate immunity 
Nutritional factors: malnutrition, alcohol consumption 
I. ANICTERIC LEPTOSPIROSIS 
This can be mild with fever, headache, and body pains or more 
severe with a biphasic illness. The septicemic phase has an abrupt onset 
with chills, rigor, fever (temperature 39°C - 40°C), severe headache, and 
body pain. The pain and weakness make walking difficult. Severe pain in 
the back, neck, abdomen, and upper limbs are frequent. The headache is 
throbbing and often severe. Anorexia, nausea, and vomiting are frequent 
and may be associated with constipation or diarrhoea. Epistaxis may 
occur during the early stage. Chest pain, dry cough, and hemoptysis may 
occur. Mental symptoms such as restlessness, confusion, delirium, 
hallucination, and occasional psychotic behavior may occur.   
The most characteristic findings on examination are conjunctival 
suffusion and severe myalgia. The conjunctival suffusion is described as 
reddening of the eye surface due to dilatation of the conjunctival 
vasculature with or without subconjunctival haemorrhage. It involves the 
bulbar conjunctiva only. A transient rash can occur. The ‘septicemia’ 
phase subsides in 4 – 7 days with temperature settling down. The second 
or immune phase is characterized by severe headache due to meningeal 
involvement, uveitis and low-grade fever. This lasts from 4 - 30 days or 
longer. The biphasic course may not be seen in all patients. 
 
II. ICTERIC LEPTOSPIROSIS 
In some patients, the septicemia phase instead of subsiding, 
progresses to a severe icteric illness with renal failure. Meningeal 
symptoms are frequent, but are overshadowed by hepatic or renal 
features. Severe bleeding, hypotension, cardiac and pulmonary 
complications are frequent. Death occurs usually due to renal failure. 
Sudden death may occur due to massive bleeding, arrhythmias, cardiac 
failure or respiratory failure. In those who are not severely ill, diuresis 
occurs and renal failure improves. The fever subsides and the general 
condition gradually improves in 2-7 days. Immunosuppressed patients 
may develop a fulminant course of leptospirosis. Two cases of Weil 
syndrome in transplant patients have been described. 42 
LIVER: Jaundice is the most important clinical feature indicating 
the severity of illness. Jaundice occurs between two to nine days and 
mostly between the fourth to sixth days but may, deepens rapidly, 
reaching a peak within a week. The liver is often enlarged and tender. 
Jaundice is mainly due to hepatocellular damage followed by intra 
hepatic cholestasis and rise in bilirubin load from absorption of tissue 
haemorrhage. Marked elevation of serum bilirubin with mildly elevated 
transaminases is characteristic.43 Death is rarely due to hepatic failure. 
 
 
KIDNEYS: Renal involvement is the commonest cause of death. 
Renal manifestations ranges from pyuria, granular casts, haematuria to 
severe renal failure. Renal manifestations are observed in all forms of 
disease irrespective of the disease severity or involved sero-group. In 
anicteric patients, microscopic haematuria, azotemia and mild proteinuria 
are noted.  
Pre renal Azotemia, if uncorrected results in tubular necrosis. 
Acute interstitial nephritis also causes renal failure. Renal failure usually 
occurs in 14 days but may occur even as early as 4 days. Renal failure is 
transient and last for few days to 2 weeks on treatment. 
HYPOTENSION: Hypotension is an important complication, 
noted in patients with severe Leptospirosis. The causes of hypotension 
are 1) Hypovolemia secondary to poor intake of feed, vomiting, and 
insensible water loss due to fever 2) massive haemorrhage mostly 
gastrointestinal 3) unidentified vasoactive endotoxin 4) widespread 
vascular injury leading to fluid shifts from intravascular to extravascular 
fluid spaces 5) myocardial dysfunction 6) adrenal hemorrhage (rarely). 
 
 
 
 
III. ATYPICAL PNEUMONIA SYNDROME 
Severe hemorrhagic pneumonitis may occur usually in the second 
week, but occasionally as early as 24 – 48 hours after onset. This may 
present with hemoptysis, chest pain, respiratory distress and cyanosis.26 
Massive hemoptysis may cause asphyxiation. Radiological abnormalities 
range from single ill-defined opacity, multiple areas of infiltration to a 
large area of consolidation. This resolves within 2 weeks without any 
residual damage. 
 
IV. HAEMORRHAGIC FEVER WITH RENAL SYNDROME 
Bleeding is a constant feature of Leptospirosis and is due to 
vascular damage.2 It is usually mild in anicteric cases but more common 
in a severely icteric patient. Bleeding may occur from respiratory, 
alimentary, renal or genital tracts and occasionally into subarachnoid 
space and adrenal glands. Death may occur from massive bleeding 
usually gastrointestinal or into internal organs. This may be associated 
with renal failure. 
 
V. MYOCARDITIS 
Cardiac complications are frequent in severe Leptospirosis. They 
are usually mild and are observed as electrocardiographic abnormalities 
ranging from low voltage complexes, non-specific ST and T wave 
changes, conduction defects and arrhythmias. Atrial fibrillation is the 
most common arrhythmia observed.44  Severe manifestations such as 
cardiomegaly, cardiac failure and severe arrhythmias due to hemorrhagic 
myocarditis are observed. Sudden death may occur from cardiac failure 
or arrhythmias. All cardiac abnormalities revert to normal within 2 to 3 
weeks. Other reported cardiac abnormalities include myocarditis and AV 
block in 44% of patients with leptospirosis.45, 46 
 
VI. OCULAR MANIFESTATIONS 
Conjunctival suffusion is a common feature of the septicemic 
phase and is usually associated with conjunctival hemorrhage. There is no 
inflammatory exudate and true conjunctivitis does not occur. It usually 
occurs in the first three days and lasts for one day to more than a week. It 
subsides within a week without any complications. More important is the 
late complication of anterior uveal tract inflammation which presents 
clinically as iritis, iridocyclitis and rarely as chorioretinitis. This may 
occur as early as the second week or may be delayed up to a year but is 
more frequent in the first 6 months. Uveitis may be unilateral or bilateral 
and the course is variable (i.e. acute benign episode, recurrent episodes or 
a chronic process). The ultimate prognosis is good but chronic Uveitis 
may cause blindness by cataract formation and hypopyon in the anterior 
chamber. An immunological basis for uveitis is suggested by the 
prolonged persistence of leptospires in the ocular fluid and the 
demonstration of agglutinins in the aqueous humour. 47  
 
VII. ASEPTIC MENINGOENCEPHALITIS 
This usually occurs in the immune phase and may present with 
signs of meningeal irritation. The CSF shows lymphocytic pleocytosis, 
raised proteins (1–2gm/L) and normal sugar. Convulsions, focal 
neurological deficits, myelitis, polyneuritis and encephalitis are rare. The 
fact that leptospires are isolated consistently from the cerebrospinal fluid 
but disappear during the onset of meningeal signs following antibody 
formation suggests that, immunological mechanism is responsible for the 
development of meningitis. Prognosis in meninigitic illness is excellent. 
VIII. UNUSUAL CLINICAL MANIFESTATIONS 
Musculoskeletal symptoms 
 
A fatal case of rhabdomyolysis was reported by O'Leary et al.51   
Skeletal muscle involvement independently correlates with the severity of 
disease.52 
Gastrointestinal manifestations  
Pai and Adhikari reported a rare case of pancreatitis following 
Leptospirosis.48 Monno and Mizushima reported a rare case of acute 
acalculus cholecystitis in a patient with infection due to serovar 
Autumnalis.49 Peritonitis is another rare manifestation of leptospirosis.50 
 
Hematological manifestations 
Somers et al reported a rare case of erythroid hypoplasia in a case of 
Leptospirosis.53  Rare immune-mediated manifestations of leptospirosis 
include antiphospholipid antibody syndrome and reactive arthritis.54, 55 
 
Endocrine abnormalities  
Panidis et al described a rare case of male hypogonadism, 
following leptospirosis presumably related to hormone deficiency at the 
hypothalamo-pituitary level. 56 Abnormalities in hormonal secretion have 
been found in experimental infection in animals but there is paucity of 
data regarding the incidence and effects of such abnormalities following 
infection in humans. 57 
 
DIFFERENTIAL DIAGNOSIS 
Leptospirosis with its varied manifestations mimics a large number 
of disease processes. In patients with fever , generalized myalgia and 
head ache,15 in first few days of fever conditions like enteric fever, 
malaria, viral hepatitis, viral fever, viral hemorrhagic fever, sepsis, 
meningitis and encephalitis should be the differential diagnosis. 3, 4, 58, 59 
Anicteric leptospirosis is usually misdiagnosed as PUO, viral fever, 
malaria, enteric fever, influenza or pyelonephritis. 
Severe Icteric leptospirosis may be confused with febrile icteric 
illness like viral hepatitis, septicemia with jaundice and malaria.  Severe 
headache, myalgia and conjunctival suffusion are constant features, and 
proteinuria is common and the onset is abrupt in leptospirosis, whereas in 
viral hepatitis, onset is gradual, headache and myalgia are mild and 
proteinuria and conjunctival suffusion are absent. Jaundice also occurs in 
malaria and sepsis. 
Leptospiral renal failure should be differentiated from renal failure 
due to malaria, sepsis and hanta virus. 
In those presenting with meningitis, leptospirosis has to be 
differentiated from bacterial and viral meningoencephalitis. Bacterial 
meningitis can be confirmed by spinal fluid examinations. Viral 
meningitis is indistinguishable from Leptospiral meningitis. 
Conjunctival suffusion, myalgia and evidence of bleeding suggest 
the diagnosis of Leptospirosis and this can be confirmed by the 
serological tests.  
 
 
DIAGNOSIS OF LEPTOSPIROSIS 
The diagnosis is established most often by serologic testing and 
less frequently by isolation of the infecting organism from clinical 
specimens. Serologic tests for leptospira include genus specific and 
serogroup specific tests. The reference method is the microscopic 
agglutination test. 1 The diagnosis is difficult to confirm, it may be 
confused with other diseases, the disease may be mild and not be 
investigated in the laboratory or laboratory tests may not be available or 
the available tests have low sensitivity during early phase of disease as 
these tests detect antibodies.60, 61 
 
 
 
 
 
 
 
 
 
 
Recommended case definition (WHO) 32 
Laboratory criteria 
Presumptive diagnosis  
A positive result of a rapid screening test such as IgM ELISA, latex 
agglutination test, lateral flow, dipstick etc.  
Confirmatory diagnosis 
1. Isolation of pathogenic Leptospires from blood or other clinical 
materials  through cultures.  
2. A positive PCR result using a validated method (primarily for 
blood and serum in the early stages of infection.  
3. Fourfold or greater rise in titer or seroconversion in microscopic 
agglutination test (MAT) on paired samples obtained at least 2 
weeks apart. A battery of Leptospira reference strains 
representative of local strains should be used as antigens in MAT.  
 
Case classification 
Suspected: 
 A case that is compatible with the clinical description and a  
presumptive laboratory diagnosis.  
Confirmed : 
  A suspected case with a confirmatory laboratory diagnosis. 
CDC CRITERIA 62 
Laboratory criteria for diagnosis  
• Isolation of Leptospira from a clinical specimen or  
• Fourfold or greater increase in Leptospira agglutination titer 
between acute and convalescent phase serum specimens obtained 
greater than or equal to 2 weeks apart and studied at the same 
laboratory or  
• Demonstration of Leptospira in a clinical specimen by 
immunofluorescence  
Case classification 
Probable:  
A clinically compatible case with supportive serologic findings 
(i.e., a Leptospira agglutination titer of greater than or equal to 200 in one 
or more serum specimens)  
Confirmed:  
A clinically compatible case that is confirmed by laboratory 
 
 
SEROLOGY:  
The serological tests for diagnosis of Leptospirosis are classified as 
genus specific tests and serovar specific tests.  
Genus specific tests: The common tests are the ELISA and 
Macroscopic slide agglutination tests (MSAT). The other tests are latex 
agglutination test, complement fixation test and haemagglutination tests. 
The genus specific tests are the investigation of choice for current 
infection. These tests are simple, more sensitive and become positive 
earlier than MAT.  
 
ELISA: ELISA detects genus specific IgM antibodies, which will be 
positive in fourth or fifth day of illness. 4, 6 Detection of IgM antibodies 
are usefull in rapid diagnosis of current infection. The test is extremely 
sensitive that all the materials used are carefully cleaned. It is best if the 
glassware is reserved exclusively for this purpose only. The ELISA test 
becomes positive a little earlier than the MAT because it is more sensitive 
to IgM antibodies. However, the test is not infallible and may be 
negative, e.g. in a large percentage of infections caused by serogroup 
Grippotyphosa and to a lesser extent, in the detection of serogroup 
Australis infections. If a variety of strains from different serogroups are 
used as antigens instead of an antigen derived from the Patoc I 
saprophytic strain, the sensitivity of the test is increased.32  
 MSAT: The slide agglutination test is a simple macroscopic test in 
which a drop of the dense suspension of leptospira is mixed with a drop 
of serum on a slide and examined by dark field microscopy. These tests 
have good sensitivity up to 85%. 2, 4-12 
 
SEROVAR SPECIFIC TESTS 
Microscopic agglutination test (MAT) 
MAT is the gold standard test for diagnosis of Leptospirosis which 
is unsurpassed for its diagnostic specificity. 1, 7, 9 The main advantage is 
that serovar can be identified which is of epidemiological importance. 
The test is complicated as it involves the use of a battery of leptospira of 
widely differing antigenic structure to cover the spectrum of leptospiral 
infection. Therefore, it requires the maintenance of stock cultures. Rising 
titers or an initial high titer is diagnostic of Leptospiral infection. These 
titers begin to rise by the end of the 2nd week and peaks in 3rd to 4th 
week, therefore are not valuable for the diagnosis of current infection. 1, 2  
Since the agglutinins stay for prolonged period after infection, a 
proportion of the healthy individuals will have detectable levels of 
antibodies. At the same time, in true patients it takes some time for the 
antibodies to reach detectable levels. These two sets of persons account 
for the false positive and false negative results of the test respectively. 
The former depends upon the endemicity of the disease in an area and 
hence the endemicity is a factor that has to be considered into account 
while fixing a cut off titer for optimal accuracy of the test. Reference 
laboratories often face this problem as they receive samples from areas of 
different endemicities. 
The high titers persists for long time, which helps in 
epidemiological surveys, but high titers from previous infection interferes 
with the diagnosis of recent infection. Considerable effort is required to 
reduce the subjective effect of observer variation, even within 
laboratories. The importance of determination of base line titers in the 
community hence cannot be overemphasized.69 
 
The difficulties in utilizing MAT are due to the following factors. 
 
a. The antibody titers raise and peak only in 2nd or 3rd week, making it a 
less sensitive test. A study of 108 cases of leptospirosis from Brazil have 
revealed that 65% of the first sample were positive by MSAT compared 
to 44% by MAT.45 
 
b. A four-fold rise in titer or seroconversion is the most definitive criteria 
for diagnosis of leptospirosis. 1, 3, 32, 62 Therefore a second sample is 
mandatory, which is difficult to obtain. In such circumstances, a single 
high titer in MAT can be taken as diagnostic criteria. As MAT titers peak 
and persist for a long time (5 - 10 years), they would interfere with 
current diagnosis.  A titer of 1:80 is considered significant, but there is 
controversy on the single diagnostic titer as they depend on endemicity. 
In endemic areas, a titer of 1:80 or 1:160 is considered low; while high 
titer is usually > 1:320 (some consider 1:640 or 1:1280 as diagnostic 
criteria). In non- endemic areas, 1/80 titer is taken as the diagnostic 
criteria. It is preferable to do rapid tests along with single high titers. 
Positive rapid tests with high titers suggest current infection while a 
negative rapid test is probably due to past infection. In Andaman, a titer 
of 1:160 is considered as diagnostic titer because of high endemicity. 
 
c. The test is complicated requiring dark field microscopy and cultures of 
various live serovars. This may not be available in small laboratories. 
 
d. Continuous risk of cross-contamination of the antigen cultures, 
necessitating periodic verification of each serovar. 
 
e. Repeated weekly subculture of large numbers of strains presents 
hazards for laboratory workers 
  MAT                            ============================ 
Other Tests 
POLYMERASE CHAIN REACTION 
PCR is promising in both sensitivity and specificity, but is 
complicated and expensive. Its value for rapid diagnosis is being 
evaluated and is used in higher centers to detect leptospires in body fluids 
like serum, urine, aqueous humour or culture supernatants. 2, 4, 5, 63-66  PCR 
can rapidly confirm the diagnosis in the early phase of the disease, when 
bacteria may be present and before antibody titers are at detectable levels. 
Positivity of IgM is 61% in cases of leptospirosis diagnosed by PCR. 67 
PCR analysis of urine can be more successful for early diagnosis of 
Leptospirosis than PCR analysis of serum. 68 
PCR requires special equipment, dedicated laboratory space and 
high skilled personnel. Conventional PCR may give false-positive results 
in the presence of minute amounts of extraneous DNA that may 
contaminate working areas. It may also give false-negative results 
because inhibitors are present in the clinical materials that are being 
examined. Although PCR technology is now widely used for the 
diagnosis of many diseases, its general value for the rapid diagnosis of 
Leptospirosis has not been evaluated worldwide as it is not yet widely 
used, particularly in tropical and subtropical countries. PCR is most 
sensitive in initial disease phase but is less sensitive than the serological 
tests over the course of the disease. 
 
Culture:  
The isolation of Leptospirosis by culture of blood, CSF and urine is 
the most definite way of confirming the diagnosis of Leptospirosis. 
Unfortunately, culture of blood does not contribute to an early diagnosis 
as results appear late, weeks or even months after inoculation of culture 
medium. Leptospires are obligatory aerobes , cultivated in a suitable 
medium at 30ºC, and are susceptible to acidic medium so need an 
optimum ph 7.2-7.4.Their generation time varies between 7–12 hours.  
The nutritional requirements  of Leptospira are unique. They can 
be grown in artificial culture media. They require Vitamin B1, B12, long 
chain fatty acids and utilize purines, but not pyrimidines. Fatty acids are 
provided by incorporating 10% rabbit serum or 5% bovine albumin into 
the medium. 1, 2 The Culture medium is hazardous to the health workers 
in research lab. Culture is rarely carried out in routine laboratories and 
this facility is available only in research centre. 
Dark-field Microscopy (DFM) 
 Demonstration of leptospires by dark ground microscopy (DGM) 
during Septicemic phase (Leptospiremic phase) is a simple technique. 
Dark ground microscopy is less expensive and simple. Microscopic 
examination of the centrifuged urine using dark-field illumination is a 
convenient and rapid diagnostic test. With a sterile bottle midstream urine 
sample is collected and stored at 4°C and transported to the laboratory as 
soon as possible.  70 
 Dark-field microscopic (DFM) examination requires a skilled 
observer to differentiate the typical movements of Leptospira from 
artefacts. It should be considered that Leptospires are very fragile and 
sensitive to the pH of the urine, so with one half of sample add 1 drop of 
formalin to 20-30 ml of urine and the other half submitted in the fresh 
state. Formalin prevents bacterial overgrowth and the fresh urine sample 
can be used for culture. The sample is negative if no spirochete observed 
in 100 fields in each of the preparations. 
 
 
MANAGEMENT 
Chemotherapy:  
The aim of chemotherapy is to eradicate Leptospirosis and to 
prevent complications. Leptospirosis is sensitive to most antibiotics. 
Antibiotic administration before the 7th day of fever reduces hospital stay 
and severity of illness. 1, 76 In paediatric age, antibiotic administration 
even after 7 days tends to reduce the complications like renal failure and 
thrombocytopenia . 76 Penicillin or tetracycline (in children > 9 years of 
age) should be started as soon as the leptospirosis is suspected. 
1,2,4,5,23,58,59, 64, 77-79
 Penicillin is the most effective antibiotic when given 
early. Parenteral penicillin G 6-8 million U/m2/day given through 
intravenous route in 6 divided doses for 7 days is the drug of choice. 1,2 
Tetracycline 10-20 mg/kg/day orally or intravenously in 4 divided doses 
for 7 days (in children more than 9 years ) can be used in those allergic to 
penicillin.1,2,5,77 Fever subsides in 24 – 36 hours. Ampicillin 25-
50mg/kg/dose Q 6th hourly or oral amoxicillin (25-50 mg/kg/day three 
times a day for 7 days) is an alternative therapy for children < 9 years of 
age. 1, 2,5,77 Erythromycin 30 mg/Kg/day divided tid is effective. 
Ciprofloxacin has been occasionally used, especially in patients with 
uveitis , the use of ciprofloxacin need more clinical trials. 64, 79 
Ceftriaxone and penicillin G were equally effective for the treatment of 
severe leptospirosis. Once-daily administration and the extended 
spectrum of Ceftriaxone against bacteria provide additional benefits over 
intravenous penicillin in institutes where typhoid and Leptospirosis may 
co exist or the disease resemble the above. 80 
Symptomatic and supportive treatment: Of primary importance is the 
meticulous attention to hydration status and maintain normal 
hemodynamic status by using intravenous fluids to avoid pre renal 
azotemia. Patients unresponsive to therapy should be managed as 
established renal failure. Headache and myalgia are treated with 
analgesics,  fever with anti pyretics, restlessness and anxiety with 
sedatives and anemia with blood transfusion. Treatment of cardiovascular 
collapse, and provision of dialysis for renal failure, is equally important. 2, 
4, 58, 73, 81  
Peritoneal dialysis has been found to be safe, simple and effective 
procedure for management of Leptospiral renal failure. If  peritoneal 
dialysis is contraindicated , hemodialysis can be done. 
 
PROGNOSIS 
Anicteric leptospirosis carry good prognosis, rarely mortality due 
to fatal pulmonary hemorrhage and myocarditis occurs.weil’s disease 
have mortality rate was upto 15%.1,2,4,58,82 overall mortality in 
leptospirosis is about 15-40% which can be reduced to 5% by proper 
management with appropriate antibiotics. Major cause of death is renal 
failure followed by massive bleeding and cardiac complications.  
It should be realized that clinical data on milder (Anicteric) forms 
of Leptospirosis is inadequate in our country and this can be made 
available only if simpler tests are done in small laboratories. There is 
paucity of data in either Faine’s or modified Faine’s criteria in children so 
far.  
 
 
 
 
 
 
 
 
 
 
 
 
REVIEW OF LITERATURE 
Faine’s and modified Faine’s criteria: 
A-Faine Solomon in 1982, at Geneva in the WHO offset publication; no. 
67, formulated a criteria for diagnosis of Leptospirosis on the basis of 
clinical, epidemiological and laboratory data. It was followed worldwide 
to diagnose Leptospirosis.  The standard Faine’s criteria had a sensitivity 
of 41.9%, specificity of 84.9% and a positive predictive value of 41.9% in 
study by Shivakumar et al.72 Faine’s criteria had a sensitivity of 88.9%, 
specificity of 80.2 %, positive predictive value of 30.8 % and negative 
predictive value of 98.6% by Rao et al. 
B-In a study by Shivakumar et al.72 106 patients with positive Faine’s 
criteria  Were analyzed. There were 69 males & 37 females. Mean age 
was 31.2 years. Outdoor manual workers (39.4%) were at risk of 
developing leptospirosis. Contaminated environment (95.2%), animal 
contact (94%)  & rainfall were the important epidemiological risk factors. 
Fever, headache & myalgia were the common clinical features. Jaundice 
(17.8%) & renal failure (10.3%) were the important complications. 
Anicteric leptospirosis (82.2%) was the common presentation. Mortality 
was nil. 
 
Part A has clinical signs and symptoms, part B epidemiological 
factors and part C has laboratory criteria for endemic and non endemic 
areas. 
The scoring is done and diagnosis is made based on the following  
Presumptive diagnosis of Leptospirosis is made if 
Part A or part A & part B score is 26 or more 
 Part A, B, C (Total): 25 or more 
A score of 20 to 25 suggests Leptospirosis as possible but unconfirmed 
diagnosis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Faine’s Criteria Modified Faine’s Criteria 
Part A : Clinical Data Part A : Clinical Data 
Question Score Question Score 
Headache 2 Headache 2 
Fever 2 Fever 2 
Temp>390C 2 Temp > 390C 2 
Conjunctival suffusion 4 Conjunctival suffusion 4 
Meningism 4 Meningism 4 
Muscle pain 4 Muscle pain 4 
Conjunctival suffusion 
Meningism 
Muscle Pain 
10 
 
Conjunctival suffusion 
Meningism 
Muscle Pain 
10 
 
Jaundice 1 Jaundice 1 
Albuminuria / Nitrogen 
Retention 
2 Albuminuria / Nitrogen 
Retention 
2 
Total Score  Total Score  
Part B : Epidemiological 
factors Contact with animals or 
Contact with known 
Contaminated water 
10 Part B : Epidemiological factors 
Rainfall 
Contact with contaminated  
Environment 
Animal contact 
Total 
 
5 
 
4 
1 
10 
Part C : Bacteriological and  
             Lab Findings  
Isolation of leptospira in 
culture – Diagnosis certain 
 
Positive Serology (MAT) 
Leptospirosis Endemic 
 Part C : Bacteriological and Lab  
             Findings  
Isolation of leptospira in culture – 
Diagnosis certain 
 
Positive Serology  
 
Single positive – Low titre 
Single positive – High titre 
 
Leptospirosis Non Endemic 
Single positive – Low titre 
Single positive – High titre 
Rising titre (Paired Sera) 
                            Total 
2 
10 
 
 
5 
15 
25 
ELISA IgM Positive 
MSAT – Positive  
MAT – Single High titre 
 
Rising titre (Paired Sera) 
 
 
                                        Total 
15 
15 
15 
 
25 
 
 
 
MODIFIED FAINE’S CRITERIA 
Certain modifications have been made in the epidemiological (Part 
B) and the laboratory criteria (Part C) of original Faine’s criteria by 
Shivakumar et al to make the diagnosis more practical in Indian 
institutions. 74 In the Modified Faine’s Criteria rapid tests (ELISA / 
MSAT) have been introduced in Part C and Rainfall has been included in 
Part B to make the diagnosis early and simple.74 Modified Faine’s criteria 
had a sensitivity of 58%, Specificity of 97.4% and positive predictive 
value (PPV) of 85.7% in study by Shivakumar et al. 74 This criteria is 
being utilized for diagnosis of Leptospirosis in district and teaching 
institutes.75 
 During an epidemic, the microbiology laboratories would be 
burdened with large number of samples for MAT. It would be impossible 
to do MAT for large number of samples as it is a complicated test. In 
addition the laboratories need to have all the serogroups, otherwise, a 
negative MAT does not exclude current Leptospirosis, if the considered 
serogroup is not available. Therefore, ELISA/MSAT is adequate for 
current diagnosis.  
History of animal contact (Part B) is not essential for diagnosis of 
Leptospirosis in developing countries. The more important 
epidemiological factors in our country are 1. Rain fall 2. Contact with 
contaminated environment. During rainfall, those who come into contact 
with water contaminated with infected rodents (or other animals) urine 
are prone to develop Leptospirosis which is facilitated by environmental 
factors. It is impossible to trace the source of infection and any person 
can be infected, irrespective of direct contact with animals. 
Thus, in the early stages of infection (5 days), clinical features are 
very important to suspect Leptospirosis utilizing Faine’s criteria (Part A). 
But the diagnosis should always be confirmed by ELISA (or) MSAT. It is 
recommended that Leptospirosis diagnosis can be done by making the 
following modification of Faine’s criteria. 81 
 
FAINE’S CRITERIA  
PART A                                                   No modification 
PART B                                               SCORE 
The score of 10 in Part B has been split into 
1. Rainfall 5 
2. 
Outdoor contact with contaminated 
environment 
4 
3. Animal contact 1 
PART C    (> 5 days) 
a) Positive ELISA/MSAT 
 
 
The reasons for the modifications are 
1. Laboratory tests are essential for diagnosis. ELISA IgM/MSAT are 
adequate for the diagnosis of current infection. If MAT were available, 
rising titers would confirm the diagnosis and identify the serovars 
2. Epidemiological factors such as rainfall and contact with contaminated 
environment are important for diagnosis. Most of the cases of 
Leptospirosis are reported in the monsoon or post monsoon season. 
3. Clinical features if combined with epidemiological and laboratory data 
confirm the diagnosis of Leptospirosis. 
C- In a study by Sunil Sethiet al and Navneet Sharma et al in PGIMER 
showed increased incidence from 11.7% in 2004 to 20.5% in 2008 as 
diagnosed by IgM elisa and MAT in paired sera. The incidence showed 
peak during rainy season. In this study modified faine’s criteria diagnosed 
76 cases (88.3%) 
D- In a study by V chayhan et al ,in adult population  . Predominant 
complaints were fever, headache, jaundice and myalgia. with history of 
contact with contaminated environment or animals, with abnormal renal 
and liver parameters. Ten were positive for IgM Elisa with 2 borderline 
positive Elisa . One PCR was positive method. Ten had Weil’s syndrome 
was the  presentation for ten patients, one had acute respiratory distress 
syndrome (ARDS) who went for ventilator care. No deaths reported in 
this study. All were treated with intravenous ceftriaxone and oral 
doxycycline. Applying Faine’s criteria was positive in 7 and  modified 
Faine’s criteria was positive in 13 . 
E-In a study by Smitha et al 2004-05 Jipmer department of microbiology 
Jipmer Pondicherry with a Sample size of 110. Seropositive rate of 
leptospirosis in and around Pondicherry is 36.3% by serovar specific 
MAT test and the prevalent serovar found is 
icterohaemorrhagicae,Pomona and pyrogen.This study shows both IgM 
elisa and MAT test were useful for the diagnosis of leptospirosis in 
suspected cases. Their study also shows the seroprevalance rate of 
leptospirosis in pyrexia of unknown origin cases in and around 
Pondicherry. 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
OBJECTIVES 
 
To assess the sensitivity and specificity of Faine’s, Modified Faine’s 
criteria and IgM Elisa in diagnosing pediatric Leptospirosis.  
 
 
 
 
 
 
 
 
 
 
 STUDY JUSTIFICATION 
 
Leptospirosis is a common zoonoses which is under reported and 
under  diagnosed in India.  It has been reported from kerala, Maharashtra, 
Andaman, Tamilnadu and Gujarat.  It is not reported from other areas 
due to lack of diagnostic facilities. The problem of under diagnosis is 
because of complicated diagnostic tests. MAT is gold standard test. But it 
is complicated, less sensitive & requires 2 samples for diagnosis. MSAT 
& ELISA has become available which has made diagnosis easy. 
 
Clinical manifestations are non-specific in the early stages of 
illness. The early institution of antibiotic therapy has been found to be 
beneficial in studies. 1, 2, 14   Faines criteria has been recommended by the 
world health organization as a useful clinical tool in the diagnosis of 
Leptospirosis.15 However, there is paucity of data in literature regarding 
the usefulness of Faine’s criteria in pediatrics. Hence, a study to assess 
the usefulness of Faines and modified Faines criteria has been attempted. 
 
 
 
 
 
MATERIALS AND METHODS 
 
Methodology 
 
Study Design  -    Descriptive study/ Evaluation of study design. 
Study place -    Institute of Child Health and Hospital for                    
     Children, Egmore, Chennai (ICH) 
Study period          -    January 2010-october 2011. 
Study population   -    91 
Inclusion criteria  
 Children from 1year to 12 years of age hospitalized for fever of more 
than 5 days duration and signs suggestive of leptospirosis with any two of 
the following features. 15 
1. Headache  
2. Myalgia / Muscle tenderness.  
3. Conjunctival suffusion  
4. Features of meningitis 
5. Jaundice 
 
 
Exclusion criteria 
 
 
Fever with obvious foci like Abscess , Cellulitis , Lymphangitis or 
any child with a confirmed diagnosis other than Leptospirosis at the time 
of discharge.  
 
Methodology 
 
 
Children satisfying the inclusion criteria were subjected to detailed 
history and thorough physical examination by a single observer. Faine’s 
and modified Faine’s scoring was carried out at the time of admission. 
Proforma was filled up. Three ml of blood sample is obtained by clean 
venipuncture with asepsis in a sterile syringe and following investigations 
were carried out Leptospira IgM Elisa, MSAT and MAT (Apart from the 
routine investigations). Blood obtained by venipuncture was allowed to 
clot at room temperature (20-25°C) and then centrifuged according to the 
National Committee for Clinical Laboratory Standards (NCCLS) 
MSAT, MAT and Leptospira IgM Elisa test was carried out in 
(Panbio- kit) were done in department of Microbiology, Madras Medical 
College, Chennai. The test was performed by the same technician, once a 
week by pooling the sample. 
The Leptospirosis laboratory, Leptospirosis research cell was 
established in July 1994 at the Institute of Microbiology, Madras Medical 
College. 
 The other tests  performed were, hemoglobin, total and differential 
counts, packed cell volume, peripheral  smear study, platelet count, smear 
for malarial parasite, erythrocyte sedimentation rate, blood widal, liver 
function tests, creatinephosphokinase, electrolytes, urea, creatinine, blood 
- enteric and non-enteric culture, CSF analysis,  chest x-ray and 
ultrasound abdomen as necessary . Second sample of blood was taken 
after 2 weeks of the 1st sample for paired sera analysis of MAT either 
before discharge or at review, whichever is feasible.  
 
MICROSCOPIC AGGLUTINATION TEST 
 
 
The MAT was performed with nine live culture antigens 
(Icterohemorrhagiae, Australis, Autumnalis, Hebdomadis, 
Grippotyphosa, Canicola, Pomona, Patoc and Bataviae) using standard 
microtiter methodology. The sera were initially screened at dilutions of 
1:20 and those that were positive were titrated further to the endpoint. 
The highest dilution of serum that agglutinated 50% of leptospires under 
dark field microscopy was presumed to represent the titer of antibody 
specific for the particular serogroup used. When two or more serogroups 
reacted at the same (highest) titer, the result was recorded as mixed equal. 
Controls were put up for each one of the battery of antigens used in the 
test. An initial titer of greater than or equal to 1: 160 or a four- fold rise in 
titer of MAT was considered significant for the diagnosis of Leptospiral 
infection. 
 
 
 
Interpretation of results 
The highest dilution of serum antigen mixture, showing 50 % 
agglutination, is taken as the end titer of the serum for that particular 
antigen. 
 
MACROSCOPIC SLIDE AGGLUTINATION TEST 
Procedure 
One drop (5 µL) of antigenic suspension was mixed with equal 
amount of serum (both heated and 1:10 diluted), on a depression slide and 
rotated on a rotator at 180 rpm for four minutes. It was examined 
macroscopically for the presence of agglutination.83 Positive and negative 
controls were also put up. 
Interpretation of results 
The results were reported as negative, 1+, 2+, 3+ and 4+ based on 
the percentage of agglutination. In our study we took 2+ and above as 
positive 
MAT and MSAT were done by a single technician and by standard 
procedures.84 
Criteria for diagnosis 
A titer more than 11 Panbio units by IgM Elisa was considered as 
diagnostic of leptospiral  infection for the purpose of the study.85 
IgM ELISA
 
Protected water for the purpose of the study was defined as either 
boiled water, UV treated, reverse osmosis process done or packaged 
mineral water. The remaining type of water supply was taken as 
unprotected water supply in this study. Monsoon season is considered 
from July to December. Animal contact was defined as rearing a pet 
animal like dog, cat or cattle at home or sighting rats at their home. 
Rainfall is scored if there is any rainfall within 21 days of the illness in 
their locality. Jaundice was given a score if there is clinical jaundice or 
laboratory evidence of bilirubin > 2.5 mg/dl. Albuminuria is considered 
as 1+ or more proteinuria by urine dipstick. Nitrogen retention is scored 
2 points when urea levels were > 40 mg/dl. Either albuminuria or 
nitrogen retention were scored. Chennai is considered as endemic area 
for the leptospirosis. 34 
ELISA – IgM 
 
Panbio Leptospira IgM ELISA test (Brisbane, Australia)   was used 
for qualitative and quantitative detection of human IgM antibodies 
directed against pathogenic Leptospira. Micro titer plates coated with 
antigen, constituted the solid phase. The kits were stored at 2-8°C in 
sealed aluminum bags with desiccant. The procedure was carried out as 
per the manufacturer’s instructions. 
The test was evaluated for each kit with the absorbance readings of 
the control sera and the calibrator sera and comparing with the acceptable 
values of these sera found on the accompanying specification sheet 
weekly. 
 
 
Results 
 
 
Positive result   : > 11        Panbio units. 
 
Low positive result :  9 - 11      Panbio units. 
 
Negative results  :  < 9          Panbio units 
 
Statistical Analysis 
Sample size was calculated on the basis of expected proportion 21% with 
confidence interval 84% and alpha error 0.05 and calculated as 91 with 
variation 40%. 
Proportion, mean and standard deviation (mean + or – sd) of the outcome 
variables as applicable will be arrived at . Faine’s criteria and IgM ELISA 
in the diagnosis of leptospirosis will be assessed by comparing their 
results with the gold standard of MAT by arriving at sensitivity 
,specificity ,positive  predictive value ,negative predictive value and 
overall accuracy 
 
 
 
 
                    
 
A total of 91 children, who fulfilled the inclusion criteria were studied as 
per protocol. With a mean age 5.412 years 57 children were male and 34 
were female gender. 
 
Figure 1: Gender distribution 
The above figure shows that 63% were
were female
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 Figure 2-
The above figure shows maximum cases reported were in between 2
years. 
 
Table 1 –
  
Age 
Group 
Total 
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 Age and gender distribution 
  Male
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Gender
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24
23
14
12
91
10-12.
3
 
 
 
 
 
 
3 
 
-6 
Table 2 
Clinical Features 
  
Present 
(%) 
Absent 
(%) Total 
Head ache 69(75.8) 22(24.2) 91(100) 
Fever 91(100) 0(0) 91(100) 
Temp >39C 91(100) 0(0) 91(100) 
Conjunctival 
Suffusion 13(14) 78(86) 91(100) 
Meningism 1(99) 90(1) 91(100) 
Muscle pain 76(84) 15(16) 91(100) 
Conjunctival 
Suffusion and 
Meningism 
7(8) 84(92) 91(100) 
Jaundice 17(19) 74(81) 91(100) 
Albuminuria/Nitrogen 
Retention 3(3) 88(97) 91(100) 
Rainfall 25(28) 66(72) 91(100) 
Contact with 
Cont.Environment 
79(87) 12(13) 91(100) 
Animal Contact 53(58) 38(42) 91(100) 
 
All had clinical Fever/Temp >39®c followed by headache and myalgia in 
descending order . 
Epidemiological features: 
Table 3- Rainfall 
Feature Number percentage 
Rain fall 25 28 
No Rain fall 66 72 
 
 
 Table 4- contact with contaminated environment
Contact with 
Cont.Environment
Present 
Absent 
 
Table 5- Animal contact
Animal Contact
Present 
Absent 
 
Serology :
MSAT : 27(30%) were sero positive with MSAT.
 
Figure 3 
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Figure 4 
In our study MAT positivity was 
 
Figure 5-
The above diagram depicts the positivity
IgM Elisa in diagnosed patients with Leptospirosis
 IgM Elisa
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 Table 6- IgM Elisa 
IgM-Positive 14 cases 
Igm-Negative 77 cases 
 
Table 7 
Effectiveness of IgM Elisa test: 
                                   MAT 
Positive Negative Total 
 
IgM 
Positive 6 8 14 
Negative 12 65 77 
Total 18 73 91 
 
Table 8 
 ESTIMATE 95  %  CI 
Sensitivity 33.3 15.6-52.3 
Specificity 89.0 84.7-93.7 
Efficacy 78 71.0-85.5 
Positive Predictive Value 42.5 20.0-67.2 
Negative Predictive Value 84.4 80.3-88.8 
False Positivity Rate 11.0 5.2-14.12 
False Negativity Rate 66.7 59.63-77.89 
Likelihood Ratio + 3.042 1.015-8.303 
Likelihood Ratio - 0.749 0.510-0.997 
Cohens Kappa test 0.224        Fair  agreement 
McNemar TEST 0.503 Not Significant 
 
Table 7 and 8 shows shows the sensitivity, specificity, 
efficacy,positivepredictive value, negative predi
positivity rate, false negativity rate , likelihood ratio +, likelihood ratio 
cohen’s kappa test and Mc’Nemar Test with 95 % confidence interval for 
IgM elisa.
 
 
 
 
Figure 6 
The above diagram depicts the positivity of MAT  MSAT and 
in diagnosed patients with Leptospirosis
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LEPTOSPIROSIS POSITIVITY: 
 
 
Figure 7 
The above figure shows distribution of MAT positivity with Positive 
Letospirosis in 18 cases with positivity rate of 19.78%. 
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Figure 8 
The above tabl
MAT. Among various serovars L.
commonly followed by icterohaemorrhagiae, 
L.autumnalis,L.pomona,L.australis,L.semarana.
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 Faine’s and modified faine’s criteria:
Table 9 
  
Letospirosis 
positive 
Letospirosis 
negative 
Total 
 
Figure 9 
The above table and figure shows the distribution of faine’s and modified 
faine’s criteria.
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Faines criteria:  
Table 10 
                                   MAT 
Positive Negative Total 
 
Faines 
Criteria 
Positive 2 21 23 
Negative 16 52 68 
Total 18 73 91 
 
Table 11 
 ESTIMATE 95  %  CI 
Sensitivity 11.1 2-32 
Specificity 71.2 69-76 
Efficacy 59.3 55.7-68 
Positive Predictive Value 8.7 1.5-25 
Negative Predictive Value 76.5 74.1-82.2 
False Positivity Rate 28.76 17.22-30.12 
False Negativity Rate 88.88 77.23-89.89 
Likelihood Ratio + 0.386 0.064-1.406 
Likelihood Ratio - 1.248 0.876-1.421 
Cohens Kappa test -0.160 slight  agreement 
McNemar TEST 0.511 NS 
 
 
 
Modified Faines criteria  :  
Table 12                                   MAT 
Positive Negative Total 
 
Modified 
Faines 
Criteria 
Positive 17 22 39 
Negative 1 51 52 
Total 18 73 91 
 
Table 13 
 ESTIMATE 95  %  CI 
Sensitivity 94.4 73-99.7 
Specificity 69.9 64.6-0.712 
Efficacy 74.7 66.3-76.8 
Positive Predictive Value 43.6 33.7-46 
Negative Predictive Value 98.1 90.7-99.9 
False Positivity Rate 30.13 18.3-31.4 
False Negativity Rate 5.55 3.45-6.01 
Likelihood Ratio + 3.314 2.063-3.457 
Likelihood Ratio - 0.080 0.004-0.417 
Cohens Kappa test 0.447 Moderate Agreement 
McNemar TEST P<0.001 Highly significant 
 
Table 11 and 13 shows shows the sensitivity, specificity, efficacy , 
positive predictive value, negative predictive value , false positivity rate , 
false negativity rate , likelihood ratio +, likelihood ratio -, cohen’s kappa 
test and Mc’Nemar Test with 95 % confidence interval for Faine’s and 
modified Faine’s criteria. 
DISCUSSION 
 
In our study of 91 children, 14(15%) of them were diagnosed to 
have Leptospirosis on the basis of positive IgM ELISA test. 
Sunil Karande S et al in Mumbai has reported a diagnosis of leptospirosis 
in 30 out of 93 (32%) children who were suspected to have the same.23 
This increase in positivity of Mumbai study might have been because 
these cases were evaluated in children living in slums and immediately 
following floods. 
Clinical diagnosis of leptospirosis  is difficult, hence a high index 
of suspicion is required for the diagnosis when a patient presents with 
fever, headache, and myalgia.81  Similar observations in the differential 
diagnosis of Leptopsirosis have been made in earlier studies. 81, 82 
AGE GROUP 
Majority of cases with leptospirosis in our series were between 2-6 
years of age (51.6%) which was similar to karande S et al. 
GENDER DISTRIBUTION 
Male: female ratio in our series was 1.7:1. It was reported to be 
1.6:1 by  karande S et al.23 There was a similar male preponderance 88 
(63%) in the study by Rajajee S et al.82 In adults the disease is 5 times 
more common in males, probably because of the occupation and 
activity.86  
TYPE OF WATER SUPPLY 
 
Nearly one fourth of the families of children with leptospirosis did 
not use protected water supply for drinking. Protected water supply can 
prevent the disease.29, 30 This finding implies the need for providing 
protected water supply to all which is very difficult in a vast country like 
ours.  
DURATION OF HOSPITAL STAY  
The duration of hospital stay was < 5 days in 50.54 %(46), between 
5 – 10 days in 37.6% (34) and between 11-15 days in 12.08%(11) 
children  in our study. This was comparable to the mean symptom 
duration of 10.1 days as reported by karande S el al .23 
 
CLINICAL FEATURES 
Headache (75.8%) and myalgia (84%) were the most common 
symptoms next to fever. Headache was reported in 54% of cases in a 
study by karande S et al, the higher occurrence of headache might have 
been, because their series had more children in the older age group.23  The 
occurrence of myalgia was similar to the observation from an earlier 
study at Chennai by Rajajee S et al which reported 24 % .82  Conjunctival 
suffusion is present in 21.9 % in our series, 15% in series of  both 
karande et al and Rajajee S et al. 23,82 Meningeal irritation was present in 
8.79% patient in our study, similar to the observation in  study by Rajajee 
S et al(7%) and meningismus was not observed in study by karande S et 
al.23,82    Less number of children in our series had jaundice (18.68 %) 
when compared to earlier reports from Mumbai (36 %) and comparable 
to reports from Chennai (18 %) . 23, 82     In adults approximately 10% of 
those infected become jaundiced.  
Outcome  
All patients recovered well in our study.  None of our patients had 
renal failure. This was similar to two studies by karande S  et al where the 
illness was relatively mild and anicteric in all the cases and the patients 
did not have any complications.3, 23  
MAT Seropositivity   
A total of 18(20%) out of 91 children in the series tested positive 
by MAT.  A  Serosurvey undertaken by Ratnam et al, among conservancy 
workers in Chennai using MAT found a seropositive prevalence rate 
ranging between 17.8% to 40.5%.93 Swapna et al from Calicut in Kerala 
has shown the seroprevalence to be 38.1% in the high-risk group vs. 24% 
in healthy controls like students and blood donors. 94     This   necessitates 
the need for caution in the  interpretation of MAT in endemic areas. 
 
IgM ELISA
 
IgM ELISA was positive in 14 patients (15%). IgM ELISA was 
performed during 5 days to 2 week in 69 patients (75.82%) and more than 
2 weeks in 22 patients (24.7%). Sensitivity and specificity of IgM Elisa 
by comparing with MAT in our study were 33.3% and 89% respectively. 
MSAT  
 MSAT was positive in 27 patients (30%). A study of 108 cases of 
leptospirosis from Brazil has revealed that 65% of the first sample 
positive by MSAT when compared to 44% by MAT.45 This low positivity 
could be because of difficulty in reading by dark field microscope. 
 
Faine’s criteria and modified Faine’s criteria 
The sensitivity of 11.1 % and specificity of 71.2% observed in our 
series for Faine’s Criteria is less than that reported by Rao et al in their 
earlier report (88.9%, 80.2%). 73 Our study was conducted only in 
children and it is possible that some of the children might not have 
complained of headache and myalgia like adults .  
Lower sensitivity observed in our series for Faine’s criteria could 
have been because our study was conducted in an endemic area in 
contrast to the study by Rao et al, which was done in a non – endemic 
area. 
 
The sensitivity and specificity (94.4%, 69.9%) for modified Faines 
criteria in our series was similar to the observations in  an earlier study in 
adults by Shivakumar et al. 81 The reason why modified Faine’s criteria 
had higher sensitivity and specificity is probably  because  IgM Elisa and 
MSAT has been used in making the diagnosis of Leptospirosis. 
 
Modified Faine’s criteria had high sensitivity and specificity 
compared to Faine’s criteria in our series, this suggests that modified 
Faine’s criteria might be more useful in the diagnosis of leptospirosis. 
Very similar observations have been made by Shivakumar et al in the 
only available study on modified Faine’s criteria in literature. 
Following are the few examples utilizing modified Faine’s criteria 
 
EXAMPLES UTILISING MODIFIED FAINE’S CRITERIA 
Patient with fever during the monsoon month with positive ELISA IgM 
Score 
A Fever 2 
B Rain Fall + Contact with contaminated environment 9 
C  ELISA Ig M positive 15 
Score = 2+9+15 = 26  
Diagnosis Leptospirosis (confirmed)  
 
 
It should be realized that clinical data on milder anicteric forms of 
Letospirosis in inadequate in our country and this can be made only if 
simple tests are done in small laboratories. 
  
 
 
 
 
 
 
 
 
 
 
 
 
Limitations of this study 
 
 
1. Cultures which are the gold standard were not performed. 
 
2.  As per WHO criteria only presumptive diagnosis of Leptospirosis was 
made. 
3. Cases in our series were studied only after the five days of the illness. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 SUMMARY  
 
This descriptive study for a period of two years was conducted in 
the Institute of child health & hospital for children, Egmore, Chennai. 
Children from age group of 1 year to 12 years with fever for more than 5 
days with signs and symptoms suggestive of leptospirosis were included 
in the study. 
Aim of the study was to evaluate Faine’s, modified Faine’s criteria 
and IgM Elisa in the diagnosis of leptospirosis. 
In our study out of 91 children 14 were diagnosed as leptospirosis 
using IgM ELISA, 23 and 39 were diagnosed as leptospirosis using 
Faine’s and modified Faine’s criteria respectively. The results were 
compared with MAT. 
Modified Faine’s criteria had high sensitivity and specificity 
compared to Faine’s criteria in our series, this suggests that modified 
Faine’s criteria might be more useful in the diagnosis of leptospirosis. 
 
  
 CONCLUSION 
 
1. Diagnosis of Leptospirosis was made by positive Leptospira IgM 
ELISA test in nearly 15.38% of children with suspected 
leptospirosis. 
2. Leptospirosis infection may masquerade as multiplicity of separate 
diseases whose clinical features vary considerably.  
3. Headache and myalgia were the predominant symptoms in addition 
to fever.  
4. The sensitivity & specificity of IgM Elisa were 33.3 % and 89 % 
respectively.  
5. The sensitivity & specificity of modified Faine’s criteria were 94.4 
% and 69.9 % respectively which was significantly higher than 
Faines criteria  
6. The sensitivity & specificity of Faine’s criteria were 11.1 % & 71.2 
% respectively. 
7. All the three serological tests (MAT, MSAT & IgM ELISA)  were 
positive only in about 3.29% of children. 
8. The occurrence of cases was higher during the monsoon. 
9. There was no mortality in our series of children with Leptospirosis.  
  
  
RECOMMENDATIONS 
 
 
Based on our observation that Modified Faine’s criteria had better 
sensitivity and specificity than Faine’s Criteria, the following 
recommendation is made. 
 
Modified Faine’s criteria might be utilized as a diagnostic test for 
leptospirosis, particularly in areas of high prevalence, so that specific 
antibiotic treatment might benefit children with leptospirosis. 
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ANNEXURE - I 
PROFORMA 
Name        Serial no. 
Age        IP no 
Sex                        DOA 
Weight       DOD 
Address             DOB                                                             
Monthly income       UNIT 
State                                             
District 
Occupation of  Father  &  Mother                
Contact no                         
Socio economic group 
Day of fever on the day of testing                  Fever settled on  
 Symptoms  
Fever              Y/N        Max recorded temperature  
Headache                          Y/N 
Myalgia                            Y/N 
Joint pain                          Y/N 
Vomiting                          Y/N 
Jaundice                            Y/N 
Abdominal pain                Y/N 
Loose stools                      Y/N 
Edema                               Y/N 
Seizures                             Y/N 
Bleeding       Epistaxis       Hematemesis      Melena     
Oliguria        Anuria           Hematuria 
Others 
 
Source of water supply                     protected/unprotected 
Animals at home                              cats      dogs      cows     rats 
Drugs before admission 
General Examination  
 
HR             RR              BP              Anemia       Transfused    y/n              
Icterus       Edema        Rashes         Temp.         Lymphadenopathy           
Facial puffiness           Muscle tenderness          conjunctival suffusion 
 
Systemic Examination 
 
CVS    
RS   
CNS     
P/A        
  
INVESTIGATIONS 
 
MAT   -  ACUTE                                   CONVALESCENT 
MSAT -  ACUTE                                        CONVALESCENT                                       
ELISA Ig M 
 
Hb                                                          PCV 
TC                                                            DC 
Total Bilirubin                                Platelet Count 
ESR                                                          Blood Culture 
AST/ALT                                                 Serum Proteins/Serum Albumin 
PT                                                             PTT 
Serum Creatinine                                      Blood Urea 
CRP                              CPK/MB                                                                        
Urine Examination                          Urine Culture 
USG Abdomen                                      CSF Analysis  
ECHO                                                       ECG 
 
Treatment given   
 
Outcome        Death            Improved         Discharged       Worsened 
Dialysis          Ventilation   ICU stay           
 
Final diagnosis                                              
Reason for exclusion 
 
                                      
                Faine’s Criteria 
 
        Modified Faine’s Criteria 
            Part A : Clinical Data                Part A : Clinical Data 
Question Score Question Score 
Headache 2 Headache 2 
Fever 2 Fever 2 
Temp > 39ºC 2 Temp > 39ºC 2 
Conjunctival 
suffusion  
4 
 
Conjunctival 
suffusion  4 
Meningism 4 Meningism 4 
Muscle pain 4 Muscle pain 4 
Conjunctival     
suffusion 
+ Meningism 
+ Muscle pain 
 
10 
Conjunctival 
suffusion 
+ Meningism 
+ Muscle pain 
 
10 
Jaundice 1 Jaundice 1 
Albuminuria/Nitrogen 
Retention 
 
2 
Albuminuria/Nitrogen 
Retention 
                                                              
2 
Total score     Total score  
    
 
  
Part C: Bacteriological and Lab 
Findings 
 
Isolation of leptospira in culture 
– Diagnosis certain                                     
Part C: Bacteriological and Lab 
Findings        
                                                           
Isolation of leptospira in culture 
– Diagnosis certain                                 
Positive Serology (MAT)       
 
Positive Serology  
         
 Leptospirosis Endemic 
 
Single positive Low titre          2 
Single positive– High titre      10 
        
 
 
Leptospirosis Non Endemic 
 
Single positive – Low titre        5        
 
Single positive– High titre        15 
 
 Rising titre (Paired sera)          25  
 
 
 
 
ELISA IgM Positive *              15   
SAT – Positive *                       15  
MAT – Single High titer*         15 
 
 
 
 
Rising titer (Paired sera)            25 
 
 
 
 Any one of the tests only should be scored 
 
 
 
 
Part B: Epidemiological factors Part B: Epidemiological Factors 
 
 
Contact with 
animals or 
Contact with 
known 
Contaminated 
water 
 
 
10 
Rainfall                     5 
Contact with 
contaminated 
environment 
 
4 
Animal contact 
1 
total total 
ANNEXURE II 
Patient Information Sheet 
Aim of the study 
To study the Evaluation of faine’s criteria and IgM ELISA in the 
diagnosis of  leptospirosis. 
Among children admitted in a tertiary care hospital. 
All datas will be kept strictly  private and confidential you may 
choose to take part or not in this study. That is your choice no penalties or 
loss of benefit will come from refusing. If you chosen to take part, you 
may refuse to answer any question. 
If you have any doubts regarding you can meet the investigator. In 
this study all investigations are done at free of cost. The treatment given 
also free of cost. 
 
SECTION -  2 
Informed Consent Form 
 I agree to participate in the study titled Evaluation of faine’s 
criteria and IgM ELISA in the diagnosis of leptospirosis. 
 I confirm that I have been told about this study in my mother 
tongue (Tamil) and I had the opportunity to ask questions. I confirm that I 
have been told about the risks and potential benefits being affected. 
 I agree not to restrict the use of any data or results that arise from 
this study. 
Name  of the child   : 
 Signature    : 
 Date     : 
Name of Guardian / care giver  : 
 Signature    : 
 Date     : 
Name of the witness  : 
 Signature    : 
 Date     : 
Name of investigator  : 
  Signature    : 
 Date     : 
  
                   îèõ™ î£œ 
 
ÝŒM¡ «ï£‚è‹: 
 °ö‰¬îèÀ‚° âL‚ è£Œ„ê™ (Leptospirosis) õ¼õ¬î 
è‡´H®ŠðîŸè£ù õNè¬÷»‹, Üî¡ àÁF î¡¬ñ¬ò»‹ ÜPõ«î 
Þ‰î ÝŒM¡ «ï£‚è‹. 
 ê†ìˆFù£™ õöƒèŠð†ìð® «êèK‚èŠð†ì Mõó‹ ÞóèCòñ£è 
ð£¶è£‚èŠð´‹. Þ‰î ÝŒM™ îƒèœ °ö‰¬î ðƒ«èŸð¶ àƒè÷¶ 
M¼Šðˆ¬î ªð£Áˆî¶. Þ‰î ÝŒM™ Þ¼‰¶ Mô°õî£™ ñ¼ˆ¶õ 
CA„¬ê ÜOŠðF™ â‰îMî ÞìÁ‹ «ïó£¶. ÝŒM™ ðƒ«èŸ°‹«ð£¶ 
Þ¬ìJ™ Môè«õ£, «èœMèÀ‚° M¬ìòO‚è£ñ™ Þ¼‚è«õ£ 
îƒèÀ‚° àK¬ñ àœ÷¶. 
 ÝŒ¾ °Pˆ¶ îƒèÀ‚° ã«îÂ‹ ê‰«îè‹ ãŸð†ì£™ 
ÝŒõ£÷¬ó «ïK™ ê‰F‚è«õ£, ªî£¬ô«ðCJ™ ªî£ì˜¹ ªè£œ÷«õ£ 
õó«õŸèŠð´Al˜èœ. 
Üð£òƒèœ ñŸÁ‹ ï¡¬ñèœ: 
 Þ‰î ÝŒM™ ðƒ«èŸðî£™ â‰îMî bƒ°‹ ãŸðì õ£ŒŠH™¬ô 
ÞF™ ðƒ«èŸ°‹ «ð£¶ ªêŒòŠð´‹ ñ¼ˆ¶õ ðK«ê£î¬ùèœ ñŸÁ‹ 
CA„¬ê ºŸP½‹ Þôõêñ£ù¶. 
åŠ¹î™: 
 Þ‰î ªî£ìó£ŒM™ ªêŒòŠð´A¡ø ªêŒº¬øè÷£™ ãŸð´‹ ð‚è 
M¬÷¾èÀ‚° ñ¼ˆ¶õ àîM ªêŒòŠð´‹. â‰îMî ïwì ß´‹ 
îóŠðìñ£†ì£¶ â¡ð¬î»‹ ÜP‰¶ ªè£‡«ì¡. 
1. ï£¡ Þ‰î .............................. «îFJ†ì îèõ™ ð®õˆ¬î ï¡ø£è 
ð®ˆ¶ è£†® â´ˆ¶¬óˆî¬î ¹K‰¶ªè£‡«ì¡. âù‚° «èœM 
«è†°‹ õ£ŒŠ¹ A¬ìˆî¶. 
2. Þ‰î ÝŒM™ ï£¡ â¡Â¬ìò ²ò ÜP«õ£´ ðƒ° ªè£œA«ø¡. 
«ñ½‹ Þ‰î ÝŒML¼‰¶ â‰îMî‚ è£óíº‹ îó£ñ™ ñ¼ˆ¶õŠ 
ðK«ê£î¬ùJL¼‰¶ ï£¡ MôA‚ ªè£œ÷ô£‹.  Þîù£™ 
ê†ìgFò£ù â‰î ªêò½‹ à†ð´ˆî£¶. 
3. Ethics °¿M¡ ÜƒèˆFù˜è«÷£, Þ‰î ÝŒM¬ù ïìˆ¶ðõ˜è«÷£ 
â¡Â¬ìò ñ¼ˆ¶õ ÝŒM¡ Ü¬ùˆ¶ Mõóƒè¬÷»‹ â¡Â¬ìò 
ÜÂñFJ¡P ð£˜‚è«õ£, ð®‚è«õ£ àK¬ñ»œ÷õ˜è÷£õ˜. ï£¡ 
Þ‰î ÝŒML¼‰¶ MôA‚ ªè£‡ì£½‹Ãì â¡Â¬ìò 
Mõóƒè¬÷ Üõ˜èœ ÜP‰¶ªè£œ÷ åˆ¶‚ªè£œA«ø¡. 
â¡Â¬ìò Mõóƒèœ Ü¬ùˆ¶‹ 3-õ¶ ïð¼‚«è£ Ü™ô¶ 
ðˆFK¬èèO™ ªõOJ´õîŸ«è£ ºòôñ£†¯˜èœ âù ï‹¹A«ø¡. 
4. Þ‰î ÝŒML¼‰¶ ªðøŠð†ì ¹œO Mõóƒè¬÷«ò£ Ü™ô¶ 
º®¾è¬÷«ò£ ðò¡ð´ˆîÃì£¶ â¡Á è†´Šð´ˆî ñ£†«ì¡. 
5. â¡ °ö‰¬î¬ò Þ‰î ñ¼ˆ¶õ ÝŒMŸ° ðƒ° ªè£œ÷ 
ðKÌóíñ£è ê‹ñF‚A«ø¡. 
¬èªò£Šð‹........................................................ «î............................. 
ªðò˜ ................................................................ 
°ö‰¬îJ¡ ªðò˜ ............................................ 
Signature of the Investigator :    Date : 
Signature of the Witnesses :    Date : 
 
                           ANNEXURE III 
                         ABBREVIATIONS 
MAT  - microscopic agglutination test 
ELISA - Enzyme-linked immunosorbent assay 
MSAT - Macroscopic slide agglutination tests 
PCR  - polymerase chain reaction  
DFM  - Dark-field Microscopy  
CDC  -  centers for disease control and prevention.  
WHO  - World health organisation 
CI  - Confidence interval 
ALT             - Alanine aminotransferase( serum glutamate pyruvate 
transaminase)  
 AST            - aspartate aminotransferase ( serum glutamic-
oxaloacetic transaminase) 
 
 
 
 
 
 
 
